The utility of novel CGM metrics in the LGA newborn prediction in women with type 1 diabetes – assessment of the cut-off values

Background: Pregnant women with type 1 diabetes (T1D) are at high risk of multiple pregnancy-related complications associated with poor glycemic control and pathologically raised insulin resistance that continuously increases throughout the pregnancy. The use of continuous glucose monitoring (CGM) devices significantly reduces the incidence of large-for-gestational-age (LGA) newborns in individuals with T1D.